Aduro Biotech Reports Fourth Quarter and Full Year 2018 Financial Results

NEXT STORY
CytomX Therapeutics Announces Full-Year 2018 Financial Results
PREV STORY
Teladoc Health Reports Fourth-Quarter and Full-Year 2018 Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

XBiotech Announces Dismissal of Class Action Lawsuit in Texas

AUSTIN, Texas, Oct. 11, 2016 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT), developer of next-generation ...

author_avatar
NASDAQ Market News

NIDDK Provides Additional Data From CyNCh Study Evaluating RP103 in Pediatric NASH at AASLD

NOVATO, Calif., Nov. 16, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (NASDAQ:RPTP) today announced ...

author_avatar
NASDAQ Market News

$112.62 Billion Precision Medicine Market Analysis & Trends 2016 – Therapeutics & Applications Forecasts to 2025

Dublin, Jan. 19, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition ...

author_avatar
NASDAQ Market News